This journal presents incisive reviews by international experts, on all aspects of pharmacology, including drug discovery and development. Coverage spans such key subjects as epigenetics and epigenomics, chemoinformatics, rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics and pharmacodynamics, modeling & simulation and pharmacometrics, and related topics in disease, including neurology and the central nervous system, cardiovascular disease, metabolic diseases, cancer and others.

  • Presents cutting-edge reviews on subjects pertinent to all aspects of pharmacology
  • Offers incisive, insightful, and balanced contributions by international leading experts
  • Benefits a wide readership of scientists and translational investigators in academia and in industry
Editor-in-chief
  • Ah-Ng Tony Kong
Publishing model
Hybrid. Open Choice – What is this?
Speed
Submission to first decision: 30 days
Acceptance to publication: 20 days
Usage
Downloads: 41,838 (2018)

Articles

Subscribe

Subscription
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2019

Advertisement

About this journal

Electronic ISSN
2198-641X
Abstracted and indexed in
  1. Chemical Abstracts Service (CAS)
  2. EBSCO Discovery Service
  3. EMBASE
  4. Google Scholar
  5. Institute of Scientific and Technical Information of China
  6. Japanese Science and Technology Agency (JST)
  7. Meta
  8. Naver
  9. OCLC WorldCat Discovery Service
  10. ProQuest-ExLibris Primo
  11. ProQuest-ExLibris Summon
  12. Reaxys
  13. SCImago
  14. SCOPUS
Copyright information

Rights and permissions

Springer Nature policies

© Springer Nature Switzerland AG